enGene Holdings Inc. (NASDAQ: ENGN) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ENGENE HOLDINGS INC.

enGene Holdings Inc. (NASDAQ: ENGN)
Listen to this Section


$1.63
-0.0950 ( -5.52% ) 675.8K

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

Market Data


Open $1.63
Previous Close $1.72
Volume 675.8K
Market Cap $111.87M
Day Range $1.63 - $1.76
52 Week Range $1.40 - $12.25
Shares Outstanding 66.99M
Change % -5.52%
Net Change ▼ -0.0950
Insider Ownership 0.03%
Exchange NASDAQ
SectorHealthcare
Industry
IPO Year2023
CountryCanada
UnderwriterUBS Investment Bank, Kempen, more

Insider Ownership Transactions

Total Amount Purchased: -4,896,018.00

Date Type Amount Purchased Purchaser
2024-11-01 Buy 561797.00 Forbion Growth Opportunities Fund I Cooperatief U.A.
2024-10-01 Buy 10000.00 Cooper Ronald Harold Wilfred
2024-07-25 Sale -110000.00 Pruthi Raj Som
2024-07-24 Sale -1250000.00 Cooper Ronald Harold Wilfred
2024-06-18 Sale -20000.00 BRUNK GERALD A
2024-06-18 Sale -20000.00 Zoth Lota S.
2024-06-18 Sale -20000.00 Glickman Richard M
2024-06-18 Sale -40000.00 Joustra Wouter
2024-06-18 Sale -40000.00 HASTINGS PAUL J
2024-06-18 Sale -20000.00 Bos Jasper

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 16, 2025
10-q Quarterly Reports 75 Jun 12, 2025
8-k 8K-related 12 Jun 12, 2025
8-k 8K-related 14 Jun 10, 2025
8-k 8K-related 13 Jun 09, 2025
8-k 8K-related 15 Jun 04, 2025

Latest News


× Before browsing our site, please accept our cookies policy